CN1823273B - 具有真阳性和真阴性被分析物对照物的紧凑型被分析物测试盒 - Google Patents
具有真阳性和真阴性被分析物对照物的紧凑型被分析物测试盒 Download PDFInfo
- Publication number
- CN1823273B CN1823273B CN200480019963.0A CN200480019963A CN1823273B CN 1823273 B CN1823273 B CN 1823273B CN 200480019963 A CN200480019963 A CN 200480019963A CN 1823273 B CN1823273 B CN 1823273B
- Authority
- CN
- China
- Prior art keywords
- test
- sample
- panel
- analyte
- tester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 174
- 239000012491 analyte Substances 0.000 title claims abstract description 44
- 239000000523 sample Substances 0.000 claims description 117
- 239000003814 drug Substances 0.000 claims description 22
- 239000012530 fluid Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 17
- 239000006172 buffering agent Substances 0.000 claims description 13
- 210000002700 urine Anatomy 0.000 claims description 12
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 239000012472 biological sample Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 claims description 7
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000010276 construction Methods 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 238000007705 chemical test Methods 0.000 claims description 2
- 210000003608 fece Anatomy 0.000 claims description 2
- 244000052769 pathogen Species 0.000 claims description 2
- 230000001717 pathogenic effect Effects 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 210000000214 mouth Anatomy 0.000 claims 4
- 238000004113 cell culture Methods 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 102000004856 Lectins Human genes 0.000 claims 1
- 108090001090 Lectins Proteins 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000003636 conditioned culture medium Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000002523 lectin Substances 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 210000003097 mucus Anatomy 0.000 claims 1
- 239000002574 poison Substances 0.000 claims 1
- 231100000614 poison Toxicity 0.000 claims 1
- 210000001215 vagina Anatomy 0.000 claims 1
- 239000013642 negative control Substances 0.000 abstract description 46
- 239000013641 positive control Substances 0.000 abstract description 33
- 238000003556 assay Methods 0.000 abstract description 6
- 238000003908 quality control method Methods 0.000 abstract description 3
- 229940121657 clinical drug Drugs 0.000 abstract 1
- 238000010324 immunological assay Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 22
- 238000007689 inspection Methods 0.000 description 18
- 239000000463 material Substances 0.000 description 15
- 230000008569 process Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 10
- 201000009032 substance abuse Diseases 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000003018 immunoassay Methods 0.000 description 7
- 229960003920 cocaine Drugs 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 4
- 206010013654 Drug abuse Diseases 0.000 description 4
- 238000003677 abuse test Methods 0.000 description 4
- 235000005607 chanvre indien Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 208000011117 substance-related disease Diseases 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 3
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 3
- -1 antibody Substances 0.000 description 3
- 235000009120 camo Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000011487 hemp Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical group [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000029797 Prion Human genes 0.000 description 2
- 108091000054 Prion Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012372 quality testing Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000012749 thinning agent Substances 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 244000261228 chanvre indien Species 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000002359 drug metabolite Substances 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000013010 irrigating solution Substances 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229910052704 radon Inorganic materials 0.000 description 1
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
- 238000010106 rotational casting Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
- G01N33/14—Beverages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
Abstract
Description
Claims (13)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48637203P | 2003-07-11 | 2003-07-11 | |
US60/486,372 | 2003-07-11 | ||
PCT/US2004/022525 WO2005006959A2 (en) | 2003-07-11 | 2004-07-12 | Compact analyte testing cassette with true positive and negative analyte controls |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1823273A CN1823273A (zh) | 2006-08-23 |
CN1823273B true CN1823273B (zh) | 2012-05-30 |
Family
ID=34079225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200480019963.0A Expired - Fee Related CN1823273B (zh) | 2003-07-11 | 2004-07-12 | 具有真阳性和真阴性被分析物对照物的紧凑型被分析物测试盒 |
Country Status (3)
Country | Link |
---|---|
US (1) | US7455813B2 (zh) |
CN (1) | CN1823273B (zh) |
WO (1) | WO2005006959A2 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7560272B2 (en) * | 2003-01-04 | 2009-07-14 | Inverness Medical Switzerland Gmbh | Specimen collection and assay container |
AU2004291923B2 (en) * | 2003-11-14 | 2011-01-20 | Alere Switzerland Gmbh | Sample collection cup with integrated activatable sample analysis system |
NZ547175A (en) | 2003-11-14 | 2009-11-27 | Oakville Hong Kong Co Ltd | Sample collection cup with integrated sample analysis system |
US20060068364A1 (en) * | 2004-09-29 | 2006-03-30 | Struck James T | Methods and devices for the prevention and treatment of gingival recession |
CN100478671C (zh) * | 2005-10-25 | 2009-04-15 | 艾康生物技术(杭州)有限公司 | 用于液体样本的检测装置和方法 |
US7527765B2 (en) | 2006-04-11 | 2009-05-05 | Harrogate Holdings | Consumer food testing device |
US20080112847A1 (en) * | 2006-11-15 | 2008-05-15 | Nancy Yu Chen | Collecting and testing device and method of use |
US8211715B1 (en) | 2011-11-15 | 2012-07-03 | Harrogate Holdings, Ltd. Co. | Consumer food testing device providing remote monitoring |
WO2013131057A1 (en) | 2012-03-01 | 2013-09-06 | Quidel Corporation | System and apparatus for point-of-care diagnostics |
CN113156107A (zh) * | 2012-03-01 | 2021-07-23 | 奎多公司 | 具有计时机制的相互作用的测试装置和设备 |
CN105748108B (zh) * | 2012-10-24 | 2019-04-05 | 艾博生物医药(杭州)有限公司 | 一种装置 |
CA152180S (en) * | 2013-02-12 | 2014-08-29 | Sulzer Mixpac Ag | Analytical apparatus for drug testing |
EP3077798B1 (en) | 2013-12-06 | 2022-06-22 | Quidel Corporation | Method for reducing analyzer variability using a normalization target |
US10330603B1 (en) * | 2016-04-08 | 2019-06-25 | Michael D. Callahan | Mass produced, low cost, portable test kit for the detection and identification of chemical and biological agents |
US9759733B1 (en) * | 2016-04-08 | 2017-09-12 | Michael D. Callahan | Mass produced, low cost, portable test kit for the detection and identification of narcotics |
ES2705099T3 (es) * | 2016-08-24 | 2019-03-21 | Protzek Ges Fuer Biomedizinische Technik Gmbh | Dispositivo para el análisis visual de analitos en una muestra líquida |
USD814652S1 (en) * | 2016-10-14 | 2018-04-03 | Spartan Bioscience In. | Cartridge |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1135259A (zh) * | 1993-09-17 | 1996-11-06 | 拉明纳公司 | 一种测定装置 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992158A (en) * | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
US4365970A (en) * | 1981-05-01 | 1982-12-28 | Smithkline Instruments, Inc. | Specimen test slide and method for testing occult blood |
US4541987A (en) * | 1983-09-29 | 1985-09-17 | Helena Laboratories Corporation | Test pad for detecting occult blood |
US4826759A (en) * | 1984-10-04 | 1989-05-02 | Bio-Metric Systems, Inc. | Field assay for ligands |
US5648274A (en) * | 1991-05-29 | 1997-07-15 | Smithkline Diagnostics, Inc. | Competitive immunoassay device |
US5976895A (en) * | 1996-03-11 | 1999-11-02 | American Biomedica Corporation | Device for the collection, testing and shipment of body fluid samples |
US5976985A (en) * | 1997-08-14 | 1999-11-02 | Micron Technology, Inc. | Processing methods of forming contact openings and integrated circuitry |
US6046058A (en) * | 1998-11-20 | 2000-04-04 | Sun; Ming | Color-coded test strip |
-
2004
- 2004-07-12 WO PCT/US2004/022525 patent/WO2005006959A2/en active Application Filing
- 2004-07-12 CN CN200480019963.0A patent/CN1823273B/zh not_active Expired - Fee Related
- 2004-07-12 US US10/890,544 patent/US7455813B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1135259A (zh) * | 1993-09-17 | 1996-11-06 | 拉明纳公司 | 一种测定装置 |
Also Published As
Publication number | Publication date |
---|---|
CN1823273A (zh) | 2006-08-23 |
WO2005006959A3 (en) | 2005-08-18 |
WO2005006959A2 (en) | 2005-01-27 |
US20050008538A1 (en) | 2005-01-13 |
US7455813B2 (en) | 2008-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1823273B (zh) | 具有真阳性和真阴性被分析物对照物的紧凑型被分析物测试盒 | |
CN101694490B (zh) | 流水线式化验装置及其使用方法 | |
JP4745245B2 (ja) | 一体化された作動可能なサンプル分析システムを有するサンプル採集カップ | |
US7927548B2 (en) | Specimen sample collection device and test system | |
EP1718410B1 (en) | Specimen sample collection device and test system | |
CN100594381C (zh) | 快速检测和保存样本的装置及其使用方法 | |
US10119968B2 (en) | Self-contained diagnostic test with advanceable test strip | |
US8025851B2 (en) | Specimen sample collection device and test system | |
US7695953B2 (en) | Apparatus for high-sensitivity body fluid testing device | |
JP2007511770A (ja) | サンプル分析システムが一体化されたサンプル採集カップ | |
CN103926241A (zh) | 一种新型检测试纸条及其制备与应用 | |
CN110252434A (zh) | 一种用于微流控芯片的液体储存结构及微流控芯片 | |
EP3117213B1 (en) | System and method for lateral flow immunoassay testing | |
US20040133128A1 (en) | Assay device with attachable seal for use with specimen collection and assay containers | |
Belsey et al. | Laboratory test analysis near the patient: Opportunities for improved clinical diagnosis and management | |
CN113304788A (zh) | 一种简易快速区分感冒感染类型的微流控装置及方法 | |
US11808672B2 (en) | Detection device | |
Mukhopadhyay | Devices to drool for | |
US20040184965A1 (en) | Testing cup | |
US20040053417A1 (en) | Diagnostic device and method of using same | |
CN212904942U (zh) | 一种样本检测器 | |
US20230084255A1 (en) | Test strip for detecting analyte in sample | |
Thorpe | Near Patient Testing. Technologies and Applications | |
Niedbala | products and technologies | |
Kirkemo | Equipment for the Side Ward, the Doctor’s Premises and the Patient’s Home |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YINWARENIS MEDICINE SWITZERLAND CO., LTD. Free format text: FORMER OWNER: OAKVILLE CO., LTD., H.K. Effective date: 20090828 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090828 Address after: Swiss CH-6300 Bourne huff Street No. 28 Applicant after: Inverness Medical Switzerland Address before: 901B, 9 / F, Jianye center, 32 Hollywood Road, central, Hongkong, China Applicant before: Oakville Hong Kong Company Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ALERE SWITZERLAND GMBH Free format text: FORMER OWNER: INVERNESS MEDICAL SWITZERLAND Effective date: 20121023 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20121023 Address after: Swiss CH-6300 Bourne huff Street No. 28 Patentee after: ALERE SWITZERLAND GMBH Address before: Swiss CH-6300 Bourne huff Street No. 28 Patentee before: Inverness Medical Switzerland |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20190712 |
|
CF01 | Termination of patent right due to non-payment of annual fee |